Evaluation of the viral reservoir in people living with HIV-1 infection and virus-driven malignancies or viral coinfections

The EVASION study was a prospective, observational, proof-of-concept study designed to quantify and characterize the HIV reservoir in people living with HIV (PLWH) on suppressive antiretroviral therapy with active oncogenic viral co-infections (HCV, EBV, HPV) and/or virus-driven malignancies, compared to co-infection-free PLWH. In the published work, the EVASION participants with active viral co-infections serve as the control group. The table and figures presented here refer to the entire EVASION cohort and are therefore not restricted to the control group included in the publication.